« Back European Journal of Cancer

Article in Press

Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer

  • Javier Rodríguez

      Affiliations

    • Unit for the Research and Treatment of Gastrointestinal Malignancies, Department of Medical Oncology, University Clinic of Navarra (CUN), Pamplona-Navarra, Spain
    • These authors contributed equally to this work.
  • ,
  • Ruth Zarate

      Affiliations

    • Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra, Spain
    • Corresponding Author InformationCorresponding author: Address: Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Avda Pio XII 55, 31008-Pamplona, Spain. Tel.: +34 948 255400; fax: +34 948 296795.
    • These authors contributed equally to this work.
  • ,
  • Eva Bandres

      Affiliations

    • Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra, Spain
  • ,
  • Valentina Boni

      Affiliations

    • Unit for the Research and Treatment of Gastrointestinal Malignancies, Department of Medical Oncology, University Clinic of Navarra (CUN), Pamplona-Navarra, Spain
  • ,
  • Amaia Hernández

      Affiliations

    • Unit for the Research and Treatment of Gastrointestinal Malignancies, Department of Medical Oncology, University Clinic of Navarra (CUN), Pamplona-Navarra, Spain
  • ,
  • Jesus Javier Sola

      Affiliations

    • Department of Pathology, University Clinic of Navarra (CUN), Pamplona-Navarra, Spain
  • ,
  • Beatriz Honorato

      Affiliations

    • Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra, Spain
  • ,
  • Nerea Bitarte

      Affiliations

    • Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra, Spain
  • ,
  • Jesus García-Foncillas

      Affiliations

    • Unit for the Research and Treatment of Gastrointestinal Malignancies, Department of Medical Oncology, University Clinic of Navarra (CUN), Pamplona-Navarra, Spain
    • Laboratory of Pharmacogenomics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona-Navarra, Spain

Published online 06 February 2012 Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(12)00012-3

doi: 10.1016/j.ejca.2012.01.007

« Back European Journal of Cancer

Article in Press